Oxaliplatin Recruiting Phase 3 Trials for Malignant Neoplasm of Stomach Treatment

clinicaltrials.gov IdentifierTitleDrugs
NCT04135781Nab-paclitaxel Combined With S-1 as Adjuvant Chemotherapy for Stage Ⅲ Gastric Cancer
NCT03745170Efficacy and Safety Evaluation of Sintilimab or Placebo in Combination With XELOX as First Line Treatment in Patients With Gastric Cancer
NCT02578368Chemotherapy Alone vs. Chemotherapy + Surgical Resection in Patients With Limited-metastatic Adenocarcinoma of the Stomach or Esophagogastric Junction
NCT03006705Study of Adjuvant ONO-4538 With Resected Gastric Cancer
NCT02555358Three Drugs in Advanced Gastric Cancer Neoadjuvant Chemotherapy for Stage Ⅲ Clinical Study
NCT03801668Albumin-bound Paclitaxel Plus S-1 Versus SOX as First-line Treatment in Advanced or Recurrent Gastric Adenocarcinoma
NCT02867839Adjuvant Chemotherapy With S-1 Plus Oxaliplatin Versus S-1 Alone in Locally Advanced Gastric Cancer
NCT01711242Trial of Adjuvant XELOX Chemotherapy and Concurrent Capecitabine and Radiotherapy for Resected Gastric Carcinoma
NCT02395640The Comparison of XELOX and EOX in the First-line Treatment of Advanced Gastric Cancer